Unaudited Consolidated Statements of Operations - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||
|---|---|---|---|---|
Jul. 31, 2024 |
Jul. 31, 2023 |
Jul. 31, 2024 |
Jul. 31, 2023 |
|
| Revenue: | ||||
| Total revenues | $ 102,115 | $ 85,830 | $ 203,332 | $ 169,675 |
| Expenses: | ||||
| Cost of revenue (excluding depreciation and amortization) | 16,143 | 14,449 | 31,866 | 29,356 |
| Payment processing expense | 16,668 | 15,852 | 34,965 | 31,942 |
| Sales and marketing | 30,184 | 37,244 | 62,195 | 74,657 |
| Research and development | 29,542 | 27,471 | 58,423 | 53,940 |
| General and administrative | 19,497 | 20,988 | 38,549 | 40,865 |
| Depreciation | 3,921 | 4,244 | 7,445 | 8,748 |
| Amortization | 3,382 | 2,537 | 6,531 | 5,023 |
| Total expenses | 119,337 | 122,785 | 239,974 | 244,531 |
| Operating loss | (17,222) | (36,955) | (36,642) | (74,856) |
| Other (expense) income, net | (86) | 50 | (117) | 8 |
| Interest income, net | 46 | 786 | 285 | 1,504 |
| Total other (expense) income, net | (40) | 836 | 168 | 1,512 |
| Loss before provision for income taxes | (17,262) | (36,119) | (36,474) | (73,344) |
| Provision for income taxes | (750) | (648) | (1,260) | (954) |
| Net loss | $ (18,012) | $ (36,767) | $ (37,734) | $ (74,298) |
| Net loss per share attributable to common stockholders, basic (in dollars per share) | $ (0.31) | $ (0.68) | $ (0.66) | $ (1.39) |
| Net loss per share attributable to common stockholders, diluted (in dollars per share) | $ (0.31) | $ (0.68) | $ (0.66) | $ (1.39) |
| Weighted-average common shares outstanding, basic (in shares) | 57,502,959 | 53,794,060 | 57,089,232 | 53,574,584 |
| Weighted-average common shares outstanding, diluted (in shares) | 57,502,959 | 53,794,060 | 57,089,232 | 53,574,584 |
| Subscription and related services | ||||
| Revenue: | ||||
| Total revenues | $ 48,612 | $ 39,301 | $ 95,354 | $ 77,188 |
| Payment processing fees | ||||
| Revenue: | ||||
| Total revenues | 25,300 | 23,631 | 52,360 | 47,884 |
| Network solutions | ||||
| Revenue: | ||||
| Total revenues | $ 28,203 | $ 22,898 | $ 55,618 | $ 44,603 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Cost of product sold and service rendered, excluding depreciation, depletion, and amortization. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of interest income (expense) classified as nonoperating. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total amount of expenses directly related to the marketing or selling of products or services. No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|